CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Providence St. Joseph Health

Michelle Woodley, Chief Nursing Informatics Officers and Nancy Yates, Chief Nursing Informatics Officers

Now That There's Agreement to Invest in Innovation, Let's Make it Meaningful

Michelle Woodley

Michelle Woodley

Healthcare digital innovation has hit a milestone. No longer are executives questioning “if” they should invest. In fact, in a recent study, more than 75 percent of healthcare executives said digital innovation is key to their long-term strategy. The question now is, “How?”


In a period of policy and financial uncertainty, how do we ensure we have the capacity to make necessary investments? And, perhaps most importantly, how do we ensure investments are clearly meaningful assets to our organization and will truly make a difference in the lives of those we touch?


Our responsibility to invest well


All of us in healthcare bear a certain responsibility. Healthcare IT dollars must be spent where it counts: Solving real problems in the healthcare sector. That means we must avoid the projects that simply sparkle yet yield little in true return. We must clearly identify those investments that assure ROI in quality and financial terms, staying true to evidence based medical science and the healing practice of care.


While tempting to implement new patient consumerism technology, the fact remains that only around 7 percent of care is actually “shopable”—as most care is episodic or urgent. However, preventive care technologies and efficiency technologies are being demanded by consumers at an ever increasing rate. We all need to dig deep and meet this challenge.


At our organization, we’ve made digital innovation a top-tier system priority. Our work in this area focuses on key strategies such as wellness and preventive care, improved clinical outcomes, and an enhanced patient and clinician experience. Every initiative must meet milestones and metrics, and contribute to extending our health system’s healing mission.


Sound investments lead the way


Let us give you some examples of what sound and successful digital innovation investments look like for our system. Take telehealth, which can be the eyes and ears of clinicians. Up in Alaska, our Anchorage specialists connect electronically with patients on the remote Unalaska Island to assist with emergencies and develop treatment plans.


Similarly, we have invested in telestroke programs that connect specialists with rural patients who now have access to specialty care they would go without if not for this technology. And one of our favorite telehealth innovations is the NICU Webcam Program, allowing worried parents and loved ones the ability to check in on their precious newborns.


Also important is to make digital innovation meaningful to every day consumers who feel much more empowered when they can participate in their health. 


For example, we’re always improving our online patient portals so patients can access their medical information, pay bills, schedule appointments or message their care provider. With our eVisits and on-demand Express Care suite of services, our patients can access a primary care provider online within minutes from their mobile device or computer to get a common care diagnosis, treatment plan and prescriptions if needed, or book an appointment.


Every initiative must meet milestones and metrics, and contribute to extending our health system’s healing mission


Some innovations can also be behind-the-scenes. For example, we were the first health system to standardize cancer pathology reporting and automate submission to the California Cancer Registry. Working with the College of American Pathology and California Cancer Registry, we were able to dramatically reduce the lag time in reporting cancer staging and facilitate the beginning of what could be a national database for patients to view treatments, locate clinical trials, and become more informed about their health status.


With predictive analytics we are just beginning to use large amounts of demographic, socioeconomic and health-record data to better predict “high risk” and intervene earlier. The pilot to better predict pressure ulcer development is in its very early stages. Sadly, many other industries are well ahead of healthcare in the use of predictive analytics and we have important work to do in this area.


Investing in teams as well as tech


We must remember that even the wisest investments are meant to be tools for our caregivers. No digital miracle, no matter how impressive, can be expected to fully comprehend a medical situation like an experienced clinician. It’s always the clinical expert who—combined with patient input—uses digital innovations as a means to develop and deliver the best treatment path. Better data and technology can help us, but it’s our expertise as clinicians that points the way. And of course, only a living, breathing clinician can offer care and compassion to an individual when it is needed most, remembering care will always be delivered one patient at a time.


That’s why, in addition to investing in innovation, our health system is attentive to the professional growth and formation of our people. We make sure that, along with having the right tools, our caregivers possess the expertise and compassion that are so necessary in healthcare today. We need to remember that this combination of investing in people and technology will always yield the best results.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/now-that-there-s-agreement-to-invest-in-innovation-let-s-make-it-meaningful-nwid-64.html